prrsv
respons
respiratori
diseas
wean
grow
pig
well
reproduct
failur
sow
consid
one
import
swine
diseas
worldwid
econom
impact
estim
million
loss
everi
year
us
produc
repres
increas
last
year
europ
situat
similar
econom
diseas
model
carri
determin
econom
burden
best
worst
case
scenario
combin
reproduct
failur
respiratori
diseas
estim
annual
loss
median
farm
slightli
affect
nurs
fatten
median
farm
sow
sever
affect
product
phase
nevertheless
scarc
inform
econom
impact
diseas
consequ
multipl
factor
vaccin
treatment
respiratori
symptom
reproduct
failur
prrsvrelat
diseas
make
difficult
task
quantifi
exactli
paramet
field
condit
thu
exact
econom
impact
prrsv
remain
key
gap
knowledg
diseas
porcin
reproduct
respiratori
syndrom
viru
prrsv
first
isol
earli
europ
north
america
envelop
singlestrand
positivesens
rna
viru
famili
arterivirida
genu
porarteriviru
accord
intern
committe
taxonomi
virus
present
four
distinct
speci
includ
genu
porarteriviru
variat
nucleotid
sequenc
along
two
virus
affect
pig
lactat
dehydrogenaseelev
viru
rat
arteriviru
genom
size
prrsv
kb
open
read
frame
orf
replicas
gene
locat
follow
gene
encod
structur
protein
toward
major
genom
encod
nonstructur
protein
involv
replic
wherea
orf
encod
structur
protein
n
e
figur
b
use
molecular
epidemiolog
studi
enorm
genet
variabl
describ
yet
data
whole
genom
sequenc
scarc
constitut
anoth
import
gap
knowledg
viru
evolut
box
prrsv
replicas
gene
consist
two
orf
occupi
proxim
threequart
genom
figur
express
viral
genom
express
depend
conserv
ribosom
frameshift
mechan
subsequ
extens
proteolyt
process
result
polyprotein
yield
least
function
nonstructur
protein
nsp
specif
part
subject
intern
cleavag
give
origin
respect
assembl
membraneassoci
replic
transcript
complex
recent
program
ribosom
frameshift
encod
altern
orf
gener
two
extra
protein
discov
prrsv
arterivirus
nsp
describ
prrsv
proven
necessari
suffici
induct
membran
modif
resembl
found
infect
cell
importantli
posit
rna
virus
seem
induc
one
two
basic
morphotyp
membran
modif
invagin
doublemembran
vesicl
prrsv
also
set
structur
protein
includ
small
nonglycosyl
protein
set
glycosyl
one
n
protein
howev
tradit
classifi
nonstructur
protein
found
incorpor
multipl
isoform
within
viral
envelop
ovarian
tumor
domain
proteas
region
hypervari
region
ctermin
region
give
new
insight
structur
viru
figur
first
nucleocapsid
protein
n
one
import
part
matur
viral
particl
deepli
character
prrsv
find
import
featur
share
nonseg
rna
virus
n
protein
consist
amino
acid
genotyp
amino
acid
genotyp
viral
envelop
glycoprotein
first
interactor
host
cell
receptor
initi
infect
expos
immun
system
viral
particl
blood
lymphoid
tissu
circul
figur
also
anoth
protein
contribut
virion
structur
protein
requir
viral
entri
interact
heparan
sulfat
cell
receptor
macrophag
later
thought
bind
sialoadhesin
viru
intern
uncoat
trigger
format
viral
heterotrim
scaveng
receptor
figur
abund
glycoprotein
first
interact
two
cell
entri
mediat
heparan
sulfat
glycosaminoglycan
favor
viral
entri
possibl
n
protein
mhclike
domain
carri
nviral
rna
complex
bud
site
figur
protect
glycan
shield
like
prrsv
membran
protein
avoid
antibodi
recognit
neutral
two
glycosyl
site
seven
four
three
directli
relat
viru
surviv
caus
lethal
damag
viru
product
two
site
mutat
figur
viral
replic
start
interact
viral
glycoprotein
differ
cellular
receptor
figur
play
main
role
infect
uncoat
viral
particl
activ
clathrinmedi
endocytosi
releas
viral
genom
cytoplasm
defin
main
receptor
viral
infect
evalu
effect
prrsv
knockout
pig
complet
resist
infect
cysteinerich
domain
receptor
seem
necessari
establish
interact
speci
sinc
delet
system
exon
gene
encod
region
impli
protect
larg
panel
virus
demonstr
vitro
challeng
editedpig
macrophag
vivo
experi
anim
import
edit
pig
show
side
effect
kept
standard
husbandri
condit
seem
maintain
biolog
function
hemoglobinhaptoglobin
scaveng
regardless
lack
cysteinerich
domain
nevertheless
unknown
function
could
impair
modif
conclus
geneedit
pig
lack
region
could
import
asset
confront
prrsv
epidem
final
goal
erad
seem
relat
cointeract
sialic
acid
virion
surfac
howev
knockout
pig
either
exon
protect
infect
viral
load
well
antibodi
respons
similar
heterozyg
wild
type
pig
former
experi
suggest
unknown
mechan
could
involv
prrsv
infect
receptor
new
unknown
suscept
cell
type
differ
macrophag
possibl
leak
express
knockout
model
molecul
also
involv
viral
entri
vimentin
block
four
molecul
vimentin
effect
viral
infect
either
intern
complet
inhibit
viral
replic
cell
entri
prrsv
caus
seri
intracellular
modif
complet
replic
cycl
includ
rearrang
intracellular
membran
organel
gener
replic
complex
includ
format
perinuclear
doubl
membran
vesicl
appar
deriv
endoplasm
reticulum
synthesi
genom
rna
grna
transcript
segment
rna
sgrna
express
viral
protein
late
stage
replic
matur
virion
accumul
intracellular
membran
compart
releas
extracellular
space
exocytosi
nonclass
spread
pathway
detect
sever
virus
includ
prrsv
viru
dissemin
mediat
cell
cell
nanotubul
report
almost
prrsv
protein
interact
myosin
actin
especi
factin
myosin
iia
nanotubul
connect
cell
allow
movement
structur
protein
rna
infect
cell
nonclass
way
even
presenc
neutral
antibodi
cell
media
addit
nonclass
pathway
demonstr
prrsv
cell
entri
receptor
necessari
establish
infect
nonpermiss
cell
becam
infect
contact
infect
cell
via
nanotub
spread
strategi
propos
mechan
facilit
infect
either
surf
viral
particl
adjac
cell
membran
receptorindepend
mechan
infect
importantli
report
virus
nanotub
number
macrophag
increas
infect
herpesviru
transmiss
bovin
fibroblast
interestingli
although
sever
viral
protein
detect
nanotubul
n
detect
nanotub
particular
role
nonclass
spread
pathway
fulli
understood
interest
evalu
interact
cellular
compon
elucid
reason
transport
new
recipi
cell
altogeth
data
indic
prrsv
evolv
differ
pathway
spread
even
though
vivo
viru
show
narrow
cell
tropism
monocyt
macrophag
box
innat
immun
respons
first
system
given
pathogen
encount
special
prevent
viral
replic
invas
mucos
tissu
respiratori
tract
case
prrsv
importantli
initi
strong
adapt
immun
respons
fight
intracellular
infecti
agent
type
interferon
ifn
compris
one
potent
mechan
invad
virus
first
stage
infect
trigger
array
ifnstimul
gene
isg
gener
speak
nucleat
cell
abil
produc
ifn
plasmacytoid
dc
pdc
potent
produc
famili
cytokin
prrsv
evolv
set
mechan
suppress
ifn
vivo
maintain
low
express
level
cytokin
infect
pig
almost
timecours
infect
shortli
transient
elev
lung
suppress
ifn
also
take
place
vitro
prrsv
infect
porcin
alveolar
macrophag
studi
shown
ifn
type
suppress
major
strategi
prrsv
modul
host
antivir
defens
fact
sever
viral
protein
identifi
ifn
antagonist
n
exampl
n
protein
upon
dsrna
stimul
product
shown
decreas
proport
increas
level
n
express
addit
found
downregul
ifndepend
gene
product
dsrna
interf
dsrnainduc
phosphoryl
nuclear
transloc
among
prrsv
nonstructur
protein
type
ifn
modul
capac
consid
strongest
antagonist
product
act
interferon
regulatori
factor
phosphoryl
nuclear
transloc
almost
nsp
except
relat
perinuclear
region
associ
intracellular
membran
supposedli
deriv
endoplasm
reticulum
er
modifi
vesicular
doublemembran
structur
viral
replic
transcript
complex
rtc
thought
associ
transloc
nucleu
first
hour
infect
capabl
inhibit
associ
crebbind
protein
cbp
promot
cbp
degrad
proteasomedepend
mechan
without
transcript
enhanceosom
may
assembl
transcript
machineri
interferon
express
recent
posttranscript
protein
express
ifn
shown
regul
prrsv
mean
upregul
cellular
mirna
porcin
alveolar
macrophag
largest
matur
prrsv
protein
contain
least
four
distinct
domain
ntermin
cpotu
domain
central
hypervari
region
put
transmembran
domain
ctermin
region
unknown
function
rich
conserv
cystein
residu
protein
uniqu
context
prrsv
due
genet
heterogen
particip
divers
role
support
viral
replic
cycl
packag
within
prrsv
virion
previou
studi
suggest
differ
role
relat
immun
evas
mechan
determin
otu
domain
thioldepend
deubiquitin
domain
inhibit
nuclear
factor
kappalightchainenhanc
activ
b
cell
nfkb
interf
polyubiquitin
process
nuclear
factor
kappa
light
polypeptid
gene
enhanc
bcell
inhibitor
subsequ
prevent
degrad
protein
moreov
viabl
delet
mutant
infect
cell
caus
downregul
cytokin
mrna
express
comparison
parent
viru
suggest
certain
region
might
contribut
induct
virusspecif
host
immun
respons
delet
region
could
produc
virul
viru
sever
isoform
share
consist
core
set
viral
strain
integr
matur
virion
final
stage
replic
figur
although
could
strainspecif
inclus
within
prrsv
virion
suggest
may
function
previous
unknown
role
relat
extracellular
function
entri
immediateearli
viral
replic
event
truncat
form
also
identifi
name
appar
role
modul
immun
evas
delet
mutant
form
use
infect
cell
signific
chang
gene
express
strong
activ
involv
cytokinecytokin
receptor
interact
tnf
signal
tolllik
receptor
signal
nodlik
receptor
signal
signal
rigilik
receptor
signal
chemokin
signal
jakstat
signal
cytosol
dnasens
nk
cell
mediat
cytotox
suggest
activ
role
direct
indirect
play
truncat
form
modul
host
cell
innat
immun
respons
make
prrsv
infecti
cycl
complic
initi
thought
nidoviru
conserv
endoribonucleas
uridylatespecif
endonucleas
nendou
demonstr
vitro
overexpress
enhanc
viral
titter
moreov
antagon
type
ifn
specif
product
activ
retino
acid
induc
gene
like
receptor
show
substrat
specif
toward
mitochondri
antivir
signal
protein
mav
rigi
transcript
protein
demonstr
activ
associ
endoribonucleas
activ
protein
transfect
mutant
virus
unabl
degrad
mav
mrna
impair
product
anoth
mechan
wherebi
protein
limit
antivir
respons
relat
inflammasom
synthesi
due
import
role
innat
adapt
immun
respons
patholog
mechan
shown
prrsv
could
activ
inflammasom
earli
stage
infect
induc
host
immunosuppress
later
measur
determin
level
mrna
matur
protein
porcin
alveolar
macrophag
pam
surpris
also
interact
rnasilenc
complex
risc
demonstr
vitro
cell
line
protein
respons
inhibit
risc
downregul
protein
express
increas
viral
titter
significantli
demonstr
direct
relationship
silenc
complex
viral
replic
least
vitro
nonstructur
protein
studi
import
gap
inform
vivo
vitro
function
interact
signal
pathway
addit
enorm
variat
among
strain
make
difficult
character
protein
variant
interact
cell
system
macrophag
dendrit
cell
dc
monocyt
other
box
recent
bodi
evid
associ
host
genet
differ
outcom
follow
prrsv
infect
respiratori
reproduct
form
diseas
although
pathway
mechan
involv
specif
diseaseresist
trait
yet
fulli
character
clear
genet
variat
diseas
resili
polygen
regul
aspect
innat
resist
acquir
immun
connect
innat
respons
averag
daili
gain
adg
prrsv
infect
associ
singl
genom
region
chromosom
best
repres
snp
tag
marker
wur
locat
noncod
region
interferoninduc
guanylatebind
protein
gene
pig
genet
resist
prrsv
infect
histor
overlook
prrsv
research
probabl
gener
confound
factor
immun
respons
studi
key
gap
knowledg
prrsv
link
pig
genet
variabl
prrsv
infect
enorm
variabl
viru
box
pig
prrsv
replic
cell
belong
innat
immun
system
pam
primari
cell
infect
lung
well
cell
monocytemacrophag
lineag
later
could
dissemin
viru
tissu
support
replic
releas
viral
particl
bloodstream
figur
moreov
prrsv
thought
abl
infect
profession
antigen
present
cell
dc
monocyt
deriv
dendrit
cell
modc
impair
normal
antigen
present
abil
induc
apoptosi
downregul
express
mhc
class
mhc
class
ii
upregul
express
induc
minim
cytokin
secret
nevertheless
new
evid
suggest
vivo
vitro
experi
specif
lung
modc
infect
virus
subtyp
one
possibl
explan
lower
express
dc
subtyp
associ
previou
result
infect
dc
cultur
condit
monocyt
vitro
could
caus
sensibil
infect
certain
strain
lena
addit
find
also
test
tonsil
cdc
tracheal
observ
cell
popul
infect
prrsv
viru
moreov
new
type
pam
character
name
porcin
intravascular
macrophag
pim
due
associ
endotheli
lung
capillari
alveoli
present
strong
capac
phagocytis
bloodrel
particl
importantli
infect
pim
cell
gave
similar
result
viral
load
deriv
infect
pam
significantli
upregul
nonsignificantli
express
infect
compar
normal
alveolar
macrophag
indic
cell
import
proinflammatori
role
prrsv
infect
lung
new
interact
cell
viru
need
explor
unravel
possibl
immunolog
featur
lead
correl
protect
recent
shown
domain
within
abl
stimul
secret
turn
inhibit
modc
function
vitro
impair
abil
modc
stimul
cell
prolifer
product
ifn
mechan
cell
activ
pdc
sever
suppress
prrsv
infect
although
cell
permiss
prrsv
infect
howev
phenomenon
strain
depend
prrsv
strain
abl
stimul
pdc
ifn
product
larg
quantiti
enorm
variabl
prrsv
strain
relat
effect
antigen
present
cell
prevent
scientist
find
common
mechan
might
interest
link
key
gap
knowledg
prrsv
host
genet
box
moreov
prrsvinfect
cell
n
abundantli
express
benefit
discontinu
transcript
mechan
protein
also
distribut
nucleu
induc
two
nuclear
local
signal
call
cryptic
nl
function
nl
posit
respect
effect
n
protein
examin
pam
modc
use
transfect
find
signific
upregul
gene
express
natur
killer
nk
cell
constitut
anoth
power
arm
innat
immun
system
prrsv
particularli
consid
high
percentag
circul
nk
cell
pig
cytotox
function
nk
cell
reduc
prrsv
infect
pig
day
infect
week
initi
studi
use
vitro
system
demonstr
stimul
porcin
nk
cell
proinflammatori
cytokin
capabl
activ
nk
cell
induc
express
high
level
perforin
caus
lysi
infect
cell
differ
scenario
appear
cell
evalu
postinfect
indic
viru
prrsv
capabl
impair
nk
cell
cytotox
vitro
nk
cytotox
prrsvinfect
pam
decreas
degranul
nk
cell
inhibit
vivo
immun
respons
observ
vitro
studi
report
approxim
half
virem
pig
reduct
nk
cellmedi
cytotox
enhanc
secret
reduc
frequenc
cytotox
tcell
doubl
posit
cell
upregul
frequenc
regulatori
cell
treg
innat
immun
respons
prrsv
obstruct
differ
mechan
adapt
respons
modest
delay
b
cell
mediat
neutral
antibodi
respons
one
main
characterist
associ
prrsv
acquir
immun
respons
even
though
prrsv
specif
antibodi
appear
earli
day
postinfect
efficaci
antibodi
remain
unclear
neutral
antibodi
take
longer
appear
nearli
month
infect
howev
passiv
transfer
neutral
antibodi
confer
almost
full
protect
prrsv
reproduct
model
offspr
aliv
challeng
pregnant
sow
high
neutral
antibodi
titter
nevertheless
anoth
experi
use
reproduct
model
presenc
prrsv
examin
transfer
neutral
antibodi
lung
tonsil
buffi
coat
cell
peripher
lymph
node
contain
replic
prrsv
similar
infect
control
although
pig
appar
protect
infect
summari
passiv
transfer
high
neutral
antibodi
titter
confer
protect
gilt
offspr
detect
viremia
elimin
presenc
viral
particl
peripher
tissu
transmiss
anim
contact
curious
role
neutral
antibodi
protect
respiratori
form
diseas
key
gap
knowledg
prrsv
point
critic
defin
precis
target
improv
vaccin
base
humor
immun
respons
viru
box
n
protein
involv
sever
mechan
immun
evas
also
one
immunogen
structur
protein
antibodi
n
appear
earli
acut
infect
togeth
protein
nonneutr
could
involv
antibodi
depend
enhanc
antibodyrel
mechan
necessarili
involv
neutral
activ
antibodydepend
cellmedi
cytotox
adcc
antibodydepend
complementmedi
cytotox
cdc
antibodydepend
complement
mediat
virolysi
adcv
examin
context
prrsv
although
none
mechan
evid
infect
deepli
investig
vitro
vivo
model
viru
import
note
neutral
antibodi
appear
late
prrsv
infect
immun
mechan
cellular
antibodi
mediat
immun
respons
might
act
suppress
viral
replic
blood
caus
viru
isol
lymphoid
tissu
maintain
suboptim
replic
final
end
viral
clearanc
type
demonstr
immun
pig
ectodomain
peptid
complex
induc
neutral
antibodi
although
ectodomainspecif
antibodi
gener
capabl
bind
viru
import
featur
make
difficult
valid
locat
neutral
epitop
number
glycosyl
around
strain
glycosyl
may
found
flank
neutral
epitop
locat
amino
acid
wherea
strain
four
potenti
glycosyl
site
test
prrsv
mutat
glycosyl
site
either
hypervari
region
upstream
neutral
epitop
enhanc
immunogen
increas
concentr
antibodi
direct
epitop
fold
higher
compar
induc
wild
type
strain
result
obtain
administ
anoth
deglycosyl
mutant
doubl
deglycosyl
put
glycosyl
moieti
twice
confer
better
protect
homolog
challeng
addit
protein
express
earli
infect
stimul
product
earli
neutral
antibodi
two
main
antivir
mechan
demonstr
role
induct
selfprotect
mechan
host
avail
data
neutral
antibodi
induc
protein
controversi
may
due
high
variat
among
prrsv
strain
previous
comment
host
genet
also
complement
small
frameshift
subgenom
mrna
call
encod
type
membran
protein
consist
primarili
alpha
helix
membranespan
domain
call
incorpor
virion
minor
compon
play
role
viral
replic
mutat
initi
codon
prematur
termin
relat
express
protein
lead
noneffici
viral
replic
lower
titter
protein
capabl
elicit
specif
antibodi
immun
respons
natur
infect
immun
although
neutral
neither
protect
challeng
trial
infect
make
difficult
defin
role
particular
small
protein
whole
immun
respons
viral
clearanc
prrsv
infect
summari
role
humor
immun
remain
elus
prrsv
infect
neutral
nonneutr
antibodi
better
character
requir
overcom
relev
gap
knowledg
box
treg
typic
increas
number
chronic
viral
diseas
prevent
persist
inflammatori
respons
patholog
damag
associ
viral
infect
convers
treg
describ
key
contributor
modul
host
immun
respons
viral
infect
cell
popul
import
compon
regul
magnitud
immun
respons
infect
virus
hiv
hcv
thu
prevent
excess
inflamm
tissu
damag
howev
also
inappropri
induc
virus
switch
balanc
immun
respons
favor
maintain
viral
replic
prrsv
role
treg
remain
unclear
appear
consequ
induct
strain
earli
day
post
infect
experi
vitro
infect
dc
exhibit
unbalanc
abil
stimul
cell
immun
respons
straindepend
manner
treg
detect
least
vitro
measur
express
marker
use
strain
case
seem
differ
viru
capabl
stimul
product
concomit
gener
treg
associ
nucleocapsid
protein
express
vitro
system
group
also
suggest
product
treg
could
relat
impair
gamma
interferon
product
alter
develop
protect
tcell
respons
inhibit
tcell
prolifer
seen
earli
stage
infect
virus
hcv
vaccin
strain
current
use
unit
state
provid
adequ
heterolog
protect
one
possibl
explan
could
lay
inabl
induc
adequ
respons
due
abil
stimul
treg
least
vitro
structur
conform
nuclear
local
express
n
protein
suggest
essenti
abil
induc
consequ
caus
induct
treg
measur
marker
note
role
nuclear
local
signal
evalu
use
delet
mutant
result
suggest
essenti
viru
surviv
although
pig
develop
significantli
shorter
durat
viremia
higher
neutral
antibodi
wildtyp
prrsvinfect
pig
role
treg
cell
immun
respons
prrsv
key
gap
knowledg
order
develop
efficaci
prrsv
vaccin
box
moreov
report
highlight
impact
prrsv
infect
thymic
cellular
mainli
loss
cell
thymu
prrsvinfect
pig
acut
lymphopenia
thymic
atrophi
lymphadenopathi
associ
presenc
prrsv
antigen
thymu
mechan
wherebi
prrsv
suppress
immun
respons
addit
presenc
prrsv
antigen
thymu
could
also
induc
toler
present
mechan
could
explain
presenc
treg
prrsv
infect
nevertheless
pictur
complet
basic
knowledg
effect
prrsv
cell
develop
thymu
would
great
interest
understand
effect
virus
host
prrsv
immunolog
thu
remain
unsolv
puzzl
due
complex
interact
differ
viral
strain
host
similar
immun
respons
could
key
featur
viru
persist
viremia
strong
inhibit
innat
cytokin
dysregul
nk
cell
function
cytotox
degranul
rapid
induct
nonneutr
antibodi
delay
appear
neutral
antibodi
late
low
tcell
respons
induct
regulatori
cell
treg
whole
neutral
antibodi
prrsvspecif
secret
cell
fulli
depict
immun
effector
function
relat
protect
immun
viral
target
relat
unknown
consequ
correl
protect
remain
elus
infect
due
labori
work
vitro
vivo
enorm
genet
divers
caus
confus
make
difficult
predict
immun
respons
one
isol
strain
could
appli
anoth
crossprotect
immun
predict
model
without
doubt
import
gap
knowledg
prrsv
lack
correl
protect
make
extrem
difficult
robust
model
check
vaccin
efficaci
diseas
box
sinc
begin
prrsv
outbreak
europ
usa
develop
efficaci
prrsv
vaccin
challeng
classic
approach
work
properli
sever
reason
viral
mutat
lead
pathogen
strain
lack
knowledg
porcin
immun
system
interact
prrsv
protein
importantli
robust
paramet
surrog
marker
unequivoc
link
viral
clearanc
thu
relationship
complet
homolog
heterolog
protect
classic
immunolog
paramet
increasedecreas
particular
cell
popul
product
neutral
antibodi
nonneutr
antibodi
clinic
outcom
addit
highli
diverg
strain
make
difficult
develop
univers
vaccin
viru
sever
differ
vaccin
prrsv
reach
market
review
recent
vaccin
reli
upon
modifi
live
viru
porcili
prr
merck
ingelvac
prrsflex
eu
boehring
ingelheim
amervacprr
hypra
syva
well
control
fostera
prr
zoeti
ingelvac
prr
mlvingelvac
prrsatp
boehring
ingelheim
also
evid
mlv
vaccin
speci
elicit
specif
humor
cellmedi
immun
cmi
respons
confer
protect
homolog
parent
strain
partial
protect
heterolog
strain
although
possibl
control
prrsv
outbreak
use
mlv
combin
good
practic
major
safeti
issu
high
mutat
rate
lead
revers
virul
recombin
among
vaccin
wild
type
strain
case
report
new
virus
introduc
consequ
mlv
vaccin
exampl
nucleotid
sequenc
ident
atyp
danish
isol
vaccin
viru
respprr
parent
viru
vaccin
viru
support
conclus
introduct
denmark
due
spread
vaccin
viru
china
recombin
event
report
prrsv
variant
nucleotid
delet
insert
nonstructur
protein
gene
also
show
possibl
recombin
event
mlv
strain
prototyp
chines
field
strain
current
inactiv
vaccin
approach
highli
effect
sinc
elicit
immun
respons
enough
prevent
spread
viru
howev
type
vaccin
augment
anamnest
viru
neutral
antibodi
virusspecif
respons
follow
wildtyp
viru
infect
prrsvmlv
vaccin
contribut
viral
clearanc
thu
combin
modifi
live
vaccin
inactiv
one
reason
approach
control
diseas
field
condit
unfortun
robust
data
compar
approach
option
avail
market
hand
inactiv
vaccin
approv
use
unit
state
due
poor
efficaci
show
challeng
trial
measur
product
prrsv
specif
neutral
nonneutr
antibodi
low
cellular
immun
respons
lead
failur
porcin
market
accord
centr
food
secur
public
health
iowa
state
univers
biosui
prr
inact
euam
approv
use
us
howev
new
strategi
evalu
overcom
problem
includ
nanoparticl
entrap
antigen
plant
base
approach
vector
vaccin
sever
attempt
made
use
structur
protein
develop
vaccin
prrsv
specif
target
neutral
antibodi
reason
one
may
hypothes
antibodi
protein
could
main
key
inhibit
viral
replic
spread
common
mani
virus
approach
vlp
combin
differ
structur
protein
test
find
anamnest
respons
possibl
boost
igg
produc
cell
previous
vaccin
infect
pig
prechalleng
period
structur
protein
abl
prime
immun
system
reduct
viremia
observ
challeng
result
suggest
viral
protein
may
target
induc
protect
respons
pig
plausibl
explan
find
may
base
presenc
neutral
epitop
sequenc
locat
variabl
region
protein
phenomena
glycan
shield
epitop
high
variabl
observ
prrsv
viru
strain
critic
gap
knowledg
prrsv
precis
character
common
epitop
present
prrsv
strain
epitop
respons
gener
effici
immun
respons
elicit
crossprotect
immun
remain
elus
taken
togeth
evid
point
need
new
vaccin
approach
compli
pathogen
free
strategi
capabl
elicit
effect
cellular
antibodi
respons
mid
long
term
protect
homolog
strain
prefer
heterolog
challeng
well
extracellular
vesicl
ev
gain
increas
scientif
attent
novel
vaccin
infecti
diseas
includ
anim
diseas
veterinari
import
capac
selfantigen
present
activ
host
cell
antibodi
immun
respons
import
induc
protect
lethal
challeng
trial
box
case
prrsv
artifici
microrna
amirna
initi
synthet
tri
suppress
express
sialoadhesin
sn
recombin
adenovir
vector
contain
exosom
caus
subexpress
sn
mrna
protein
level
reduc
viral
titter
porcin
macrophag
pretreat
amirna
thu
provid
new
evid
support
hypothesi
ev
also
serv
effici
small
rna
transfer
vehicl
pig
cell
recent
prrsv
viral
protein
associ
extracellular
vesicl
ev
size
rang
exosom
report
moreov
targetedpig
trial
use
ev
sera
infect
pig
overcom
diseas
demonstr
ev
capabl
induc
specif
secret
cell
primeboost
strategi
safe
freeofviru
differenti
infect
vaccin
anim
moreov
demonstr
ev
contain
antigen
viral
protein
recogn
pig
immun
sera
preimmun
one
interest
howev
recent
articl
indic
prrsv
deriv
ev
capabl
transmit
viru
one
cell
anoth
whether
discrep
due
vivo
vs
vitro
experiment
work
method
appli
isol
ev
serum
sampl
cultur
supernat
remain
determin
ev
also
explor
novel
control
strategi
viral
diseas
exampl
respiratori
syncyti
viru
infect
ev
releas
select
modifi
cargo
compar
uninfect
epitheli
cell
analyz
detail
sever
viral
protein
divers
speci
rna
detect
capabl
activ
innat
immun
respons
induct
cytokin
chemokin
releas
similar
scenario
viral
protein
export
ev
observ
extens
review
ebv
viral
diseas
moreov
viral
product
variou
origin
size
includ
ebola
viru
np
influenza
viru
np
crimeancongo
haemorrhag
fever
np
west
nile
viru
hepat
c
viru
fuse
nef
ctermin
domain
dna
vector
direct
ev
membran
packag
remain
stabl
fusion
importantli
inject
mice
dna
vector
express
divers
fusion
product
elicit
well
detect
antigen
specif
cell
respons
associ
cytotox
activ
potent
enough
kill
peptideload
andor
antigenexpress
syngen
cell
prove
promis
result
cytotox
lymphocyt
vaccin
prrsv
complex
diseas
sever
gap
knowledg
econom
impact
biolog
evolut
genet
polymorph
mechan
viral
infect
elicit
protect
immun
respons
novel
control
strategi
review
box
sinc
late
differ
approach
permit
examin
close
viru
allow
discoveri
new
featur
complex
replic
cycl
identif
protein
nucleic
acid
play
role
togeth
extracellular
vesicl
nanotubul
facilit
spread
better
understand
immun
evas
nonneutr
antibodi
glycan
shield
mutat
recombin
event
among
other
vaccin
develop
present
avail
prrsv
vaccin
mani
limit
term
heterolog
protect
effort
made
combin
new
adjuv
formul
modifi
live
virus
dna
peptid
vaccin
well
extracellular
vesicl
new
vaccin
approach
advanc
gap
knowledg
eventu
acceler
elimin
eventu
erad
devast
veterinari
diseas
huge
econom
import
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
review
sg
declar
past
supervisori
role
one
author
mm
handl
editor
